DEDICATED TO SAVING LIVES
BY TRANSFORMING AT-HOME
CANCER DETECTION

Early identification of Cancer saves lives.

To be effective, cancer detection needs to be simple, readily available, and affordable.

We develop innovative products that quickly and reliably identify the early onset of several leading deadly conditions – such as colorectal (“CRC”) and pancreatic cancer.

Our goal is to place effective solutions where they need to be… In your hands.

Mainz BioMed (NASDAQ: MYNZ) – was founded in Germany and is becoming a leading global provider of easy-to-use diagnostic solutions for patients and healthcare providers everywhere.

OUR COMPANY

OUR BUSINESS

OUR SOLUTION

LATEST NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy

Corporate News

MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY

Corporate News

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium